May 11, 2004

Compounds of the formula I ##STR1## useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.

20

May 11, 2004

09/788,687

February 21, 2001

514/252.11   514/252.12 514/252.14 514/252.18 514/252.19 514/253.01 514/254.01 544/295 544/357 544/360 544/364 544/370 544/383

C07D   401/12   (20060101)   C07D   239/00   (20060101)   C07D   241/16   (20060101)   C07D   239/26   (20060101)   C07D   241/12   (20060101)   C07D   241/00   (20060101)   C07D   213/00   (20060101)   C07D   213/64   (20060101)   C07D   213/74   (20060101)   C07D   401/00   (20060101)  

Feb 21, 2000 [EP] 00400467

544/295   544/357   544/360   544/364   544/370   544/383   514/252.11   514/252.12   514/252.14   514/252.18   514/252.19   514/253.01   514/254.01  

7153857 - Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents - Owned by AstraZeneca AB (Sodertalje,SE) Compounds of the formula I ##STR00001## useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.